BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Eisai and Biogen Announce Approval of LEQEMBI® (Lecanemab) for Alzheimer’s Disease Treatment in Hong Kong

LEQEMBI is now available for patients with mild cognitive impairment (MCI) or mild dementia, collectively referred to as early AD, the population in which ...

July 11, 2024 | News

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

July 01, 2024 | News

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Conclude Successfully

The fourth Asia Summit on Global Health (ASGH) and the 15th Hong Kong International Medical and Healthcare Fair (Medical Fair) have conclud...

May 20, 2024 | News

Pfizer's Innovative Single-Dose Bivalent RSV Vaccine Approved in Hong Kong and Macau

The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...

May 09, 2024 | News

Everest Medicines Secures NDA Approval for Nefecon® in Hong Kong, Expanding Treatment Reach in Asia

Everest Medicines announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropath...

May 02, 2024 | News

PolyU Partners with ZEISS Vision Care to Advance Global Myopia Control

The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalm...

April 26, 2024 | News

Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases

In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...

March 13, 2024 | News

CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare

The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...

March 12, 2024 | News

Luye Pharma Launches Zepzelca® (Lurbinectedin) in Hong Kong, Macao

A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support...

March 07, 2024 | News

HKUST Neuroscientists Unveil Groundbreaking Blood Test for Alzheimer's with Over 96% Accuracy

Neuroscientists from the Hong Kong University of Science and Technology (HKUST), led by Prof. Nancy IP, have introduced a highly accurate universal diagnos...

February 20, 2024 | News

DKSH Hong Kong Renews Partnership with Church & Dwight, Expands Anusol Availability

This partnership renewal underscores DKSH's commitment to delivering exceptional healthcare solutions and mutual success in the pha...

February 09, 2024 | News

Agilis Robotics Reveals Innovative Breakthroughs in Endoluminal Surgery

This achievement empowers surgeons to perform intricate tissue resection procedures with precision and ease, directly within natural orifices. Uniquely, th...

February 05, 2024 | News

InnoCare Prescribes Tafasitamab Combo for Diffuse Large B-Cell Lymphoma in Greater Bay Area's Early Access Program

The early access program of the Greater Bay Area allows designated medical institutions in the area to access drugs and medical devices that have been appr...

January 22, 2024 | News

HKBU's New Chinese Medicine Drug for Myofibrillar Myopathy Granted FDA Orphan Drug Designation

Success in obtaining orphan drug (a drug used for treating rare disease) designation will accelerate the approval process of the new drug, including speedi...

January 10, 2024 | News

Stay Connected